BioSpecifics Technologies announces beginning of XIAFLEX® Phase II Trial

NEW YORK, USA| BioSpecifics Technologies Corp., a biopharmaceutical company developing first in class collagenase-based products marketed as XIAFLEX in the U.S. and XIAPEX® in Europe and Eurasia, announced recently More...

GW Pharmaceuticals seeks FDA permission for Sativex

Sativex, is the world’s first marijuana based prescription drug, developed by GW Pharmaceuticals, a British pharmaceutical company. This drug, developed as a mouth spray, has two best known psychoactive ingredients More...

MRI- compatible pacemakers, now in India

On Tuesday, St. Jude Medical said that it has released an “MRI-conditional” pacemaker in India. This pacemaker would enable patients with the implants to undergo some full-body MRI scans. As per the More...

Smith & Nephew’s PICO system is now FDA approved

Smith & Nephew plc has announced the FDA clearance of the pocket-sized PICO system, a single use Negative Pressure Wound Therapy (NPWT) system. PICO is cleared for use both in a hospital and homecare setting More...

FDA Grants clearance to a disinfecting port protector

Carlsbad, California (USA) – Ivera Medical Corporation today announced that it has received a new FDA 510(k) clearance for its Curos disinfecting port protector. The Curos passive disinfection cap  first More...